Catalent Net Income 2012-2019 | CTLT

Catalent annual/quarterly net income history and growth rate from 2012 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Catalent net income for the quarter ending September 30, 2019 was $-0.008B, a 44.44% decline year-over-year.
  • Catalent net income for the twelve months ending September 30, 2019 was $0.144B, a 119.88% increase year-over-year.
  • Catalent annual net income for 2019 was $0.137B, a 64.35% increase from 2018.
  • Catalent annual net income for 2018 was $0.084B, a 23.86% decline from 2017.
  • Catalent annual net income for 2017 was $0.11B, a 1.52% decline from 2016.
Catalent Annual Net Income
(Millions of US $)
2019 $137
2018 $84
2017 $110
2016 $112
2015 $212
2014 $16
2013 $-50
2012 $-24
2011 $-54
Catalent Quarterly Net Income
(Millions of US $)
Q1 2019 $-8
Q4 2019 $71
Q3 2019 $32
Q2 2018 $49
Q1 2018 $-14
Q4 2018 $83
Q3 2018 $19
Q2 2017 $-22
Q1 2017 $4
Q4 2017 $62
Q3 2017 $26
Q2 2016 $17
Q1 2016 $5
Q4 2016 $58
Q3 2016 $11
Q2 2015 $31
Q1 2015 $12
Q4 2015 $154
Q3 2015 $32
Q2 2014 $47
Q1 2014 $-20
Q4 2014 $27
Q3 2014 $7
Q2 2013 $-19
Q1 2013 $2
Q4 2013
Q3 2013
Q4 2012
Q4 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.643B $2.518B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.340B 10.01
Zoetis (ZTS) United States $59.218B 35.42
Astellas Pharma (ALPMY) Japan $32.299B 16.13
Eisai (ESALY) Japan $21.220B 40.92
Grifols, S.A (GRFS) Spain $15.628B 20.48
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.519B 19.81
Neurocrine Biosciences (NBIX) United States $10.262B 484.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.752B 17.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.480B 10.83
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
IPSEN SA ADR (IPSEY) France $7.310B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.443B 97.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.026B 18.07
FibroGen (FGEN) United States $4.157B 122.15
United Therapeutics (UTHR) United States $4.114B 0.00
Nektar Therapeutics (NKTR) United States $3.833B 0.00
Sage Therapeutics (SAGE) United States $3.761B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.591B 13.13
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.941B 0.00
ArQule (ARQL) United States $2.413B 0.00
Heron Therapeutics (HRTX) United States $2.302B 0.00
Zogenix (ZGNX) United States $2.136B 0.00
Xencor (XNCR) United States $2.127B 64.65
Portola Pharmaceuticals (PTLA) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.979B 63.10
ChemoCentryx (CCXI) United States $1.932B 0.00
Tilray (TLRY) Canada $1.903B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.899B 56.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.721B 0.00
USANA Health Sciences (USNA) United States $1.654B 17.64
Corcept Therapeutics (CORT) United States $1.527B 18.56
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.507B 10.29
Enanta Pharmaceuticals (ENTA) United States $1.295B 29.58
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.196B 0.00
Karyopharm Therapeutics (KPTI) United States $1.068B 0.00
Endo (ENDP) Ireland $1.066B 1.96
Radius Health (RDUS) United States $1.034B 0.00
Aerie Pharmaceuticals (AERI) United States $1.024B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.983B 0.00
Flexion Therapeutics (FLXN) United States $0.795B 0.00
Akebia Therapeutics (AKBA) United States $0.755B 0.00
Dermira (DERM) United States $0.702B 0.00
Collegium Pharmaceutical (COLL) United States $0.694B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
ImmunoGen (IMGN) United States $0.542B 0.00
Translate Bio (TBIO) United States $0.535B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Ardelyx (ARDX) United States $0.470B 0.00
Organogenesis Holdings (ORGO) United States $0.445B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.445B 54.00
BioSpecifics Technologies Corp (BSTC) United States $0.440B 18.98
BioCryst Pharmaceuticals (BCRX) United States $0.439B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.436B 0.00
Harpoon Therapeutics (HARP) United States $0.435B 0.00
Molecular Templates (MTEM) United States $0.413B 0.00
Indivior (INVVY) United States $0.412B 1.49
OptiNose (OPTN) United States $0.393B 0.00
Recro Pharma (REPH) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.379B 0.00
Innate Pharma SA (IPHYF) France $0.375B 0.00
DURECT (DRRX) United States $0.371B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.30
Siga Technologies (SIGA) United States $0.369B 8.43
Corbus Pharmaceuticals Holdings (CRBP) United States $0.329B 0.00
Rafael Holdings (RFL) United States $0.312B 0.00
Jounce Therapeutics (JNCE) United States $0.306B 4.09
KalVista Pharmaceuticals (KALV) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.272B 0.00
GlycoMimetics (GLYC) United States $0.267B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Concordia (CXRXF) Canada $0.215B 0.00
Concert Pharmaceuticals (CNCE) United States $0.210B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 32.00
AcelRx Pharmaceuticals (ACRX) United States $0.184B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Aquestive Therapeutics (AQST) United States $0.168B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.129B 0.00
CV Sciences (CVSI) United States $0.129B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.089B 0.00
Capnia (SLNO) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 23.91
Oasmia Pharmaceutical AB (OASMY) Sweden $0.079B 0.00
Champions Oncology (CSBR) United States $0.078B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Natural Alternatives (NAII) United States $0.058B 14.55
Genocea Biosciences (GNCA) United States $0.058B 0.00
Novan (NOVN) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Mast Therapeutics (SVRA) United States $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
IsoRay (ISR) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Shineco (TYHT) China $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00